Clinical Trial Access in Low- and Middle-Income Countries: A Case Study on India

The global burden of cancer is estimated to be more than 20 million cases by 2030, the majority occurring in low- and middle- income countries (LMICs).1 LMICs account for 64% of global cancer death...